S-921

N/A

Report date: 2023/12/19 17:11:52
NME

Base Information

Drug NameS-921
Drug Alias NameS-921S921
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGhrelin/growth hormone secretagogue receptor agonistsSphingomyelin phosphodiesterase inhibitors
TargetsSphingomyelin phosphodiesteraseGhrelin/growth hormone secretagogue receptor
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAmyloid Solution Inc
China Registration ClassN/A

Develop Information

Active CompaniesAmyloid Solution Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A